Published in Respiration on August 31, 2016
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med (2011) 6.74
Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med (2004) 5.78
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med (2008) 2.29
Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med (2007) 2.13
Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med (2006) 1.98
Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med (2002) 1.85
Macula densa cell signaling involves ATP release through a maxi anion channel. Proc Natl Acad Sci U S A (2003) 1.85
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia (2005) 1.78
Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med (2005) 1.77
Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest (2005) 1.72
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet Respir Med (2013) 1.69
Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis. Am J Surg Pathol (2004) 1.67
Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest (2007) 1.66
Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity. Am J Respir Crit Care Med (2012) 1.55
Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med (2005) 1.52
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest (2010) 1.52
Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J Cell Biol (2003) 1.51
Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration (2005) 1.42
Episode analysis of deposition of radiocesium from the Fukushima Daiichi nuclear power plant accident. Environ Sci Technol (2013) 1.36
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med (2010) 1.34
Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer (2002) 1.32
Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis. N Engl J Med (2008) 1.30
Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med (2004) 1.27
Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology (2012) 1.26
Chronic cystic lung disease: diagnostic accuracy of high-resolution CT in 92 patients. AJR Am J Roentgenol (2003) 1.25
Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir Med (2006) 1.24
Early intervention can improve clinical outcome of acute interstitial pneumonia. Chest (2006) 1.22
Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest (2009) 1.22
A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2002) 1.20
Acute fibrinous and organizing pneumonia: initial presentation as a solitary nodule. J Thorac Imaging (2005) 1.19
Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. Vaccine (2005) 1.18
Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology (2009) 1.15
The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors. Respirology (2007) 1.14
Quantitative CT in chronic obstructive pulmonary disease: inspiratory and expiratory assessment. AJR Am J Roentgenol (2009) 1.13
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis (2014) 1.12
Novel prophylactic and therapeutic vaccine against tuberculosis. Vaccine (2009) 1.12
Pulmonary alveolar proteinosis. Clin Chest Med (2004) 1.11
Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages. Proc Natl Acad Sci U S A (2004) 1.10
Severe acute interstitial lung disease after crizotinib therapy in a patient with EML4-ALK-positive non-small-cell lung cancer. J Clin Oncol (2012) 1.06
Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med (2005) 1.05
Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung. J Pathol (2003) 1.05
Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med (2007) 1.02
A case of lymphomatoid granulomatosis/angiocentric immunoproliferative lesion with long clinical course and diffuse brain involvement. J Neurol Sci (2003) 1.02
Response rate is associated with prolonged survival in patients with advanced non-small cell lung cancer treated with gefitinib or erlotinib. J Thorac Oncol (2009) 1.02
Cyclophosphamide-induced late-onset lung disease. Intern Med (2003) 1.00
Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Oncogene (2003) 1.00
Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler Thromb Vasc Biol (2003) 0.99
Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan. Int J Clin Oncol (2012) 0.97
A new tool to assess sarcoidosis severity. Chest (2006) 0.95
Reliability of the proposed international classification of high-resolution computed tomography for occupational and environmental respiratory diseases. J Occup Health (2009) 0.95
Chronic eosinophilic pneumonia due to visceral larva migrans. Intern Med (2002) 0.93
Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth. Am J Respir Cell Mol Biol (2003) 0.92
Strategies for expanding colorectal cancer screening at community health centers. CA Cancer J Clin (2013) 0.92
Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest (2005) 0.92
Recurrence of bilateral diffuse bronchiectasis after bilateral lung transplantation. Respirology (2006) 0.91
Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis. BMC Pulm Med (2014) 0.90
WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases. Microbiol Immunol (2004) 0.90
CD9 overexpression suppressed the liver metastasis and malignant ascites via inhibition of proliferation and motility of small-cell lung cancer cells in NK cell-depleted SCID mice. Oncol Res (2005) 0.90
De novo vertebral artery dissecting aneurysm after contralateral vertebral artery occlusion--two case reports. Neurol Med Chir (Tokyo) (2006) 0.90
Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. Nutr Cancer (2003) 0.89
St. George's Respiratory Questionnaire has longitudinal construct validity in lymphangioleiomyomatosis. Chest (2013) 0.89
Nonspecific interstitial pneumonia: a real clinical entity? Clin Chest Med (2004) 0.89
Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan. Respirology (2006) 0.89
Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J Recept Signal Transduct Res (2006) 0.88
Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis. Hum Vaccin (2011) 0.88
Images in clinical medicine. Diaphragmatic hernia. N Engl J Med (2004) 0.88
Life-threatening and Rapidly Growing Teratoma in the Anterior Mediastinum. Intern Med (2015) 0.88
Pollution of montane soil with Cu, Zn, As, Sb, Pb, and nitrate in Kanto, Japan. Sci Total Environ (2010) 0.88
Pyothorax-associated angiosarcoma of the pleura with metastasis to the brain. Pathol Int (2003) 0.87
Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis. Respir Med (2011) 0.87
Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than anti-TNF-α antibody in mice. Clin Dev Immunol (2011) 0.87
A case of large-cell neuroendocrine carcinoma harboring an EML4-ALK rearrangement with resistance to the ALK inhibitor crizotinib. J Thorac Oncol (2014) 0.87
Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma. Cancer Sci (2009) 0.87
Spatial distribution of maxi-anion channel on cardiomyocytes detected by smart-patch technique. Biophys J (2007) 0.86
Using NOAA AVHRR data to assess flood damage in China. Environ Monit Assess (2003) 0.86
Caspase-3 expression in human gastric carcinoma and its clinical significance. Oncology (2004) 0.86
Solitary atypical adenomatous hyperplasia in the lung of a 17-year-old man with spontaneous pneumothorax. Respiration (2003) 0.85
The herbal medicine Shosaiko-to exerts different modulating effects on lung local immune responses among mouse strains. Int Immunopharmacol (2002) 0.85
Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment. Respirology (2013) 0.85
Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF. Respir Med (2004) 0.85
Small-cell lung cancer in never-smokers: a case series with information on family history of cancer and environmental tobacco smoke. Clin Lung Cancer (2011) 0.85